|
1
|
Boor P, Ostendorf T and Floege J: Renal
fibrosis: novel insights into mechanisms and therapeutic targets.
Nat Rev Nephrol. 6:643–656. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Eddy AA: Molecular basis of renal
fibrosis. Pediatr Nephrol. 15:290–301. 2000. View Article : Google Scholar
|
|
3
|
Stahl PJ and Felsen D: Transforming growth
factor-β, basement membrane, and epithelial-mesenchymal
transdifferentiation: implications for fibrosis in kidney disease.
Am J Pathol. 159:1187–1192. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
López-Hernández FJ and López-Novoa JM:
Role of TGF-β in chronic kidney disease: an integration of tubular,
glomerular and vascular effects. Cell Tissue Res. 347:141–154.
2012. View Article : Google Scholar
|
|
5
|
Mozes MM, Böttinger EP, Jacot TA and Kopp
JB: Renal expression of fibrotic matrix proteins and of
transforming growth factor-β (TGF-β) isoforms in TGF-β transgenic
mice. J Am Soc Nephrol. 10:271–280. 1999.PubMed/NCBI
|
|
6
|
Zhang C and Zhang F: The multifunctions of
WD40 proteins in genome integrity and cell cycle progression. J
Genomics. 3:40–50. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kiely PA, Sant A and O'Connor R: RACK1 is
an insulin-like growth factor 1 (IGF-1) receptor-interacting
protein that can regulate IGF-1-mediated Akt activation and
protection from cell death. J Biol Chem. 277:22581–22589. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Berns H, Humar R, Hengerer B, Kiefer FN
and Battegay EJ: RACK1 is up-regulated in angiogenesis and human
carcinomas. FASEB J. 14:2549–2558. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Battaini F, Pascale A, Paoletti R, Govoni
S and Battaini F: The role of anchoring protein RACK1 in PKC
activation in the ageing rat brain. Trends Neurosci. 20:410–415.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qian L, Shi J, Zhang C, Lu J, Lu X, Wu K,
Yang C, Yan D, Zhang C, You Q, et al: Downregulation of RACK1 is
associated with cardiomyocyte apoptosis after myocardial
ischemia/reperfusion injury in adult rats. In Vitro Cell Dev Biol
Anim. 52:305–313. 2016. View Article : Google Scholar
|
|
11
|
Hu F, Tao Z, Wang M, Li G, Zhang Y, Zhong
H, Xiao H, Xie X and Ju M: RACK1 promoted the growth and migration
of the cancer cells in the progression of esophageal squamous cell
carcinoma. Tumor Biol. 34:3893–3899. 2013. View Article : Google Scholar
|
|
12
|
Jia D, Duan F, Peng P, Sun L, Liu X, Wang
L, Wu W, Ruan Y and Gu J: Up-regulation of RACK1 by TGF-β1 promotes
hepatic fibrosis in mice. PloS One. 8:e601152013. View Article : Google Scholar
|
|
13
|
Sato M, Muragaki Y, Saika S, Roberts AB
and Ooshima A: Targeted disruption of TGF-β1/Smad3 signaling
protects against renal tubulointerstitial fibrosis induced by
unilateral ureteral obstruction. J Clin Invest. 112:1486–1494.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou P, Shi L, Li Q and Lu D:
Overexpression of RACK1 inhibits collagen synthesis in keloid
fibroblasts via inhibition of transforming growth factor-β1/Smad
signaling pathway. Int J Clin Exp Med. 8:15262–15268. 2015.
|
|
15
|
Blom IE, Goldschmeding R and Leask A: Gene
regulation of connective tissue growth factor: new targets for
antifibrotic therapy? Matrix Biol. 21:473–482. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gao X, Li J, Huang H and Li X: Connective
tissue growth factor stimulates renal cortical myofibroblast-like
cell proliferation and matrix protein production. Wound Repair
Regen. 16:408–415. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yokoi H, Mukoyama M, Nagae T, Mori K,
Suganami T, Sawai K, Yoshioka T, Koshikawa M, Nishida T, Takigawa
M, et al: Reduction in connective tissue growth factor by antisense
treatment ameliorates renal tubulointerstitial fibrosis. J Am Soc
Nephrol. 15:1430–1440. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xiao Y, Liu J, Peng Y, Xiong X, Huang L,
Yang H, Zhang J and Tao L: GSTA3 attenuates renal interstitial
fibrosis by inhibiting TGF-beta-induced tubular
epithelial-mesenchymal transtion and fibronection expression. PloS
One. 11:e01608552016. View Article : Google Scholar
|
|
19
|
Wei MG, Sun W, He WM, Ni L and Yang YY:
Ferulic acid attenuates TGF-β1-induced renal cellular fibrosis in
NRK-52E cells by inhibiting Smad/IlK/Snail pathway. Evid Based
Complement Alternat Med. 2015:6197202015. View Article : Google Scholar
|
|
20
|
Samarakoon R, Overstreet JM, Higgins SP
and Higgins PJ: TGF-β1 → SMAD/p53/USF2 → PAI-1 transcriptional axis
in ureteral obstruction-induced renal fibrosis. Cell Tissue Res.
347:117–128. 2012. View Article : Google Scholar
|
|
21
|
Murphy M, Docherty NG, Griffin B, Howlin
J, McArdle E, McMahon R, Schmid H, Kretzler M, Droguett A, Mezzano
S, et al: IHG-1 amplifies TGF-β1 signaling and is increased in
renal fibrosis. J Am Soc Nephrol. 19:1672–1680. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Huang C, Shen S, Ma Q, Chen J, Gill A,
Pollock CA and Chen XM: Blockade of KCa3.1 ameliorates renal
fibrosis through the TGF-β1/Smad pathway in diabetic mice.
Diabetes. 62:2923–2934. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Han Y, Lu JS, Xu Y, Zhang L and Hong BF:
Rutin ameliorates renal fibrosis and proteinuria in
5/6-nephrectomized rats by anti-oxidation and inhibiting activation
of TGFβ1-smad signaling. Int J Clin Exp Pathol. 8:4725–4734.
2015.
|
|
24
|
Shi Y and Massagué J: Mechanisms of TGF-β
signaling from cell membrane to the nucleus. Cell. 113:685–700.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hwang M, Kim HJ, Noh HJ, Chang YC, Chae
YM, Kim KH, Jeon JP, Lee TS, Oh HK, Lee YS, et al: TGF-β1 siRNA
suppresses the tubulointerstitial fibrosis in the kidney of
ureteral obstruction. Exp Mol Pathol. 81:48–54. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schnaper HW, Jandeska S, Runyan CE,
Hubchak SC, Basu RK, Curley JF, Smith RD and Hayashida T: TGF-beta
signal transduction in chronic kidney disease. Front Biosci
(landmark Ed). 14:2448–2465. 2009. View
Article : Google Scholar
|
|
27
|
Liu N, Tolbert E, Pang M, Ponnusamy M, Yan
H and Zhuang S: Suramin inhibits renal fibrosis in chronic kidney
disease. J Am Soc Nephrol. 22:1064–1075. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vindevoghel L, Lechleider RJ, Kon A, de
Caestecker MP, Uitto J, Roberts AB and Mauviel A: SMAD3/4-dependent
transcriptional activation of the human type VII collagen gene
(COL7A1) promoter by transforming growth factor β. Proc Natl Acad
Sci USA. 95:14769–14774. 1998. View Article : Google Scholar
|
|
29
|
Lan HY: Diverse roles of TGF-β/Smads in
renal fibrosis and inflammation. Int J Biol Sci. 7:1056–1067. 2011.
View Article : Google Scholar :
|
